TCR2 Therapeutics所有資訊

TCR2 Therapeutics | 4：持股變動聲明-股東 TANG KEVIN C

02/15 06:29

TCR2 Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(0%),TANG CAPITAL MANAGEMENT, LLC(0%)等

02/15 05:03

TCR2 Therapeutics | 15-12G：終止註冊

2023/06/12 19:00

TCR2 Therapeutics | EFFECT：其他

2023/06/06 12:15

TCR2 Therapeutics | EFFECT：其他

2023/06/06 12:15

TCR2 Therapeutics | EFFECT：其他

2023/06/06 12:15

TCR2 Therapeutics | 4：持股變動聲明-股東 UBS Oncology Impact Fund L.P.

2023/06/06 04:37

TCR2 Therapeutics | 4：持股變動聲明-股東 MPM SunStates Fund, L.P.

2023/06/06 04:36

TCR2 Therapeutics | 4：持股變動聲明-股東 MPM BioVentures 2014, L.P.

2023/06/06 04:36

TCR2 Therapeutics | 4：持股變動聲明-董事 GADICKE ANSBERT

2023/06/06 04:35

TCR2 Therapeutics | POS AM：修改註冊聲明表

2023/06/02 04:45

TCR2 Therapeutics | POS AM：修改註冊聲明表

2023/06/02 04:44

TCR2 Therapeutics | POS AM：修改註冊聲明表

2023/06/02 04:43

TCR2 Therapeutics | S-8 POS：員工福利計劃證券登記(修正)

2023/06/02 04:41

TCR2 Therapeutics | S-8 POS：員工福利計劃證券登記(修正)

2023/06/02 04:41

TCR2 Therapeutics | S-8 POS：員工福利計劃證券登記(修正)

2023/06/02 04:40

TCR2 Therapeutics | S-8 POS：員工福利計劃證券登記(修正)

2023/06/02 04:39

TCR2 Therapeutics | S-8 POS：員工福利計劃證券登記(修正)

2023/06/02 04:38

TCR2 Therapeutics | 4：持股變動聲明-董事 Allen Andrew R

2023/06/02 04:33

TCR2 Therapeutics | 4：持股變動聲明-董事 Tomasello Shawn

2023/06/02 04:32